2m 2m 2m 2m 2m 2m 2m
RAPD MICRO BIO-A (RPID)
NASDAQ
$1.97+$0.005 (+0.26%)
Price as of Jun 03, 2026 6:22 PM EDT- $91.1MMarket Cap
- -47.45%1-Year Change
- Medical DevicesIndustry
RAPD MICRO BIO-A (RPID)
$1.97+$0.005 (+0.26%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 23.4M -16.49% | 28.1M +24.57% | 22.5M +31.44% | 17.1M -26.25% | |
Cost of Revenue | 26.0M -7.75% | 28.2M +0.56% | 28.0M +9.08% | 25.7M -17.11% | |
Gross Profit | -2.6M +2,242.20% | -109,000 -98.01% | -5.5M -35.77% | -8.5M +10.32% | |
Sales and Marketing Expense | 12.1M -8.93% | 13.3M -0.42% | 13.3M -11.15% | 15.0M +26.91% | |
Research and Development Expense | -13.6M -6.81% | -14.6M +13.86% | -12.8M -0.36% | -12.9M +31.54% | |
Depreciation and Amortization Expense | 3.3M -3.27% | 3.4M +8.28% | 3.1M +9.45% | 2.8M +85.55% | |
Total Operating Expenses | 81.0M +3.86% | 78.0M -1.41% | 79.1M -1.58% | 80.4M +14.03% | |
Operating Profit | -47.4M -5.06% | -49.9M -11.75% | -56.6M -10.53% | -63.2M +33.85% | |
Interest Income | 1.5M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -1.0M N/A | N/A N/A | N/A N/A | -2.5M -5.66% | |
Interest Income and Expense and Net | 509,000 N/A | 0 N/A | 0 +100.00% | -2.5M -5.66% | |
Total Nonoperating Income and Expense | 309,000 -89.88% | 3.1M -26.05% | 4.1M +124.66% | 1.8M +107.01% | |
Income before Taxes | -47.1M +0.46% | -46.9M -10.62% | -52.4M -14.57% | -61.4M -16.41% | |
Income Taxes | 40,000 +81.82% | 22,000 -29.03% | 31,000 +105.38% | -576,000 -732.97% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -47.1M +0.50% | -46.9M -10.63% | -52.5M -13.71% | -60.8M -17.30% | |
Net Income from Continuing Operations Applicable to Common | -47.1M +0.50% | -46.9M -10.63% | -52.5M -13.71% | -60.8M -22.08% | |
Basic EPS and Net Income | -1.05 -2.78% | -1.08 -11.48% | -1.22 -14.69% | -1.43 -63.71% | |
Diluted EPS and Net Income | -1.05 -2.78% | -1.08 -11.48% | -1.22 -14.69% | -1.43 -63.71% | |
Basic Weighted Average Shares | 44.7M +2.53% | 43.6M +1.28% | 43.0M +1.34% | 42.5M +114.59% | |
Diluted Weighted Average Shares | 44.7M +2.53% | 43.6M +1.28% | 43.0M +1.34% | 42.5M +114.59% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 20.0M +18.44% | 16.9M -30.36% | 24.3M -10.27% | 27.1M -84.83% | |
Short-Term Investments | 18.3M -45.99% | 33.8M -50.09% | 67.8M -16.93% | 81.6M +439.93% | |
Cash and Cash Equivalents and Short-Term Investments | 38.3M -24.51% | 50.7M -44.89% | 92.1M -15.27% | 108.6M -43.85% | |
Total Current Assets | 61.2M -24.41% | 80.9M -32.80% | 120.4M -13.11% | 138.6M -36.47% | |
Accumulated Depreciation | 19.3M +16.80% | 16.5M +15.45% | 14.3M +21.25% | 11.8M +0.14% | |
Property and Plant and Equipment and Net | 9.0M -19.84% | 11.2M -12.77% | 12.8M -7.14% | 13.8M +22.24% | |
Total Long-Term Assets | 319,000 -39.92% | 531,000 -31.04% | 770,000 -31.19% | 1.1M -24.95% | |
Total Assets | 74.9M -23.75% | 98.2M -31.57% | 143.5M -24.76% | 190.7M -20.95% | |
Income Taxes Payable | 269,000 +14.47% | 235,000 -6.75% | 252,000 -41.26% | 429,000 -51.31% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 18.5M +5.25% | 17.6M -7.48% | 19.0M -0.34% | 19.1M +4.87% | |
Total Long-Term Debt | 18.9M N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Long-Term Liabilities | 397,000 +33.22% | 298,000 +13.31% | 263,000 +14.85% | 229,000 -81.07% | |
Total Liabilities | 41.6M +82.52% | 22.8M -10.39% | 25.5M -3.84% | 26.5M +31.17% | |
Retained Earnings | -522.4M +9.91% | -475.3M +10.95% | -428.4M +13.96% | -375.9M +19.30% | |
Total Stockholders Equity | 33.2M -55.93% | 75.4M -36.14% | 118.0M -28.13% | 164.2M -25.71% | |
Total Shares Outstanding | 40.0M -53.56% | 86.1M +1.48% | 84.8M +101.51% | 42.1M +1.51% | |
Cash Flow | |||||
Cash from Operating Activities | -31.1M -29.65% | -44.2M -2.06% | -45.1M -23.00% | -58.5M +6.52% | |
Capital Expenditures | 850,000 -37.73% | 1.4M -26.02% | 1.8M -72.63% | 6.7M +109.51% | |
Cash from Investing Activities | 14.3M -60.91% | 36.7M -13.04% | 42.2M +145.10% | -93.5M +603.36% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 19.8M +9,639.41% | 203,000 +36.24% | 149,000 -78.50% | 693,000 -99.68% | |
Financials Ratio | |||||
Gross Margin | -10.90% +2,704.45% | -0.39% -98.40% | -24.36% -51.13% | -49.85% N/A | |
Operating Margin | -202.31% +13.68% | -177.96% -29.15% | -251.18% -31.93% | -368.99% N/A | |
Return on Assets | -54.47% +40.35% | -38.81% +23.57% | -31.41% +11.52% | -28.16% N/A | |
Return on Equity | -86.82% +78.99% | -48.50% +30.42% | -37.19% +17.78% | -31.58% N/A | |
Revenue Growth | -16.49% -167.12% | 24.57% -21.86% | 31.44% +219.75% | -26.25% N/A | |
Current Ratio | 3.31 -28.18% | 4.61 -27.37% | 6.34 -12.81% | 7.27 N/A | |
Cash Ratio | 1.08 +12.54% | 0.96 -24.73% | 1.28 -9.97% | 1.42 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow